Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Steatocystoma multiplex

Diseases of the Skin and Subcutaneous Tissue

Steatocystoma multiplex is a benign, usually autosomal dominant congenital condition in which a person develops multiple small cysts, generally 2 to 20 millimeters across but sometimes swelling to 4 to 6 centimeters when inflamed. The cysts form from abnormal lining of the sebaceous ducts that carry oil from skin glands and have been linked to defects in Keratin 17; most cases run in families, though sporadic cases can appear as new mutations with no prior family history. Cysts typically first appear around puberty, likely triggered by hormonal stimulation of hair follicles and oil glands, and present as soft to firm, semi-translucent bumps filled with an oily yellow liquid. They occur most often on the chest but can also appear on the abdomen, upper arms, armpits and face, and when inflamed can become intensely painful and interfere with everyday movement.

Facts
Classification
Body System
Integumentary System 1
ICD-10 Chapter
XII: Diseases of the Skin and Subcutaneous Tissue 2
Communicable or Non-communicable
Non-Communicable 3
Causative Agent
Causative Agent (category)
Genetic / Hereditary 3
Sources
1. National Library of Medicine MeSH: Steatocystoma Multiplex
National Library of Medicine MeSHMeSH tree number C17.800.827.250.856.500
Quote, MeSH tree number C17.800.827.250.856.500
<http://id.nlm.nih.gov/mesh/D062685> <http://id.nlm.nih.gov/mesh/vocab#treeNumber> <http://id.nlm.nih.gov/mesh/C17.800.827.250.856.500> .
View the Source
2. Wikidata: Steatocystoma multiplex
Wikidata P494 (L72.2)View the Source
3. Steatocystoma multiplex (Wikipedia)
  • lead sentence 1
    Steatocystoma multiplex is a benign, autosomal dominant congenital condition resulting in multiple cysts on a person's body.
  • Lead: disease category
    Steatocystoma multiplex is a benign, autosomal dominant congenital condition resulting in multiple cysts on a person's body.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.